We are live on ! Find out more
PCM

Parsons Capital Management Portfolio holdings

AUM $2.21B
1-Year Est. Return 28.12%
This Fund
S&P 500
This Quarter Est. Return
+12.76%
1 Year Est. Return
+28.12%
3 Year Est. Return
+84.89%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.13%
AUM
$996M
AUM Growth
+$73M
Cap. Flow
-$4.39M
Cap. Flow %
-0.44%
Top 10 Hldgs %
32.34%
Holding
361
New
17
Increased
88
Reduced
159
Closed
12

Top Buys

Rank Stock Value
1
RLMD icon
Relmada Therapeutics
RLMD
+$11.1M
2
BMY icon
Bristol-Myers Squibb
BMY
+$3.4M
3
TFC icon
Truist Financial
TFC
+$2.17M
4
FENY icon
Fidelity MSCI Energy Index ETF
FENY
+$1.55M
5
IBM icon
IBM
IBM
+$1.33M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$6.06M
2
MMM icon
3M
MMM
+$6.04M
3
STI
SunTrust Banks, Inc.
STI
+$2.12M
4
STZ icon
Constellation Brands
STZ
+$1.69M
5
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$1.45M

Sector Composition

Rank Sector Weight
1 Technology 19.34%
2 Healthcare 13.59%
3 Financials 12.59%
4 Industrials 12.28%
5 Consumer Discretionary 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VUG icon
226
Vanguard Morningstar Growth ETF
VUG
$231B
$628K 0.06%
20,670
+216
+1% +$6.24K
D icon
227
Dominion Energy
D
$59.3B
$616K 0.06%
7,440
-100
-1% -$8.17K
CHTR icon
228
Charter Communications
CHTR
$18.2B
$609K 0.06%
1,256
– –
GE icon
229
GE Aerospace
GE
$384B
$605K 0.06%
10,880
+2,107
+24% +$109K
KMB icon
230
Kimberly-Clark
KMB
$36.5B
$605K 0.06%
4,400
+12
+0.3% +$1.62K
HAL icon
231
Halliburton
HAL
$26.6B
$598K 0.06%
24,440
-7,975
-25% -$168K
COF icon
232
Capital One
COF
$134B
$594K 0.06%
5,773
+31
+0.5% +$2.99K
EEMV icon
233
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.56B
$592K 0.06%
10,092
+6,597
+189% +$383K
AEP icon
234
American Electric Power
AEP
$68.4B
$581K 0.06%
6,149
-41
-0.7% -$3.79K
RDS.B
235
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$581K 0.06%
+9,691
New +$571K
SCCO icon
236
Southern Copper
SCCO
$166B
$578K 0.06%
+14,670
New +$511K
YUM icon
237
Yum! Brands
YUM
$41.1B
$577K 0.06%
+5,726
New +$593K
FBIN icon
238
Fortune Brands Innovations
FBIN
$6.06B
$570K 0.06%
10,201
– –
AVGO icon
239
Broadcom
AVGO
$2.04T
$546K 0.05%
17,280
+820
+5% +$24.9K
GLW icon
240
Corning
GLW
$143B
$545K 0.05%
18,725
-1,069
-5% -$31K
TRAK icon
241
ReposiTrak
TRAK
$159M
$535K 0.05%
105,762
-59,980
-36% -$308K
GILD icon
242
Gilead Sciences
GILD
$165B
$519K 0.05%
7,988
-300
-4% -$19.5K
OEF icon
243
iShares S&P 100 ETF
OEF
$20.6B
$519K 0.05%
3,604
– –
CERN
244
DELISTED
Cerner Corp
CERN
$508K 0.05%
6,921
– –
TRV icon
245
Travelers Companies
TRV
$80.2B
$504K 0.05%
3,677
– –
DD icon
246
DuPont de Nemours
DD
$19.2B
$492K 0.05%
6,101
-1,786
-23% -$148K
CI icon
247
Cigna
CI
$74.6B
$480K 0.05%
2,345
-2,264
-49% -$415K
AKAM icon
248
Akamai
AKAM
$15.9B
$479K 0.05%
5,550
– –
SUSA icon
249
iShares ESG Optimized MSCI USA ETF
SUSA
$4.18B
$473K 0.05%
7,054
– –
TTWO icon
250
Take-Two Interactive
TTWO
$46.1B
$465K 0.05%
3,795
– –
8 9
10
11 12

Similar funds

WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
IFA
Index Fund Advisors Irvine, California $2.22B AUM 20.66% 1-Year Est. Return
DPCM
Darlington Partners Capital Management Greenbrae, California $2.23B AUM 16.2% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.23B AUM 15.01% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
NP
NS Partners London, United Kingdom $2.23B AUM 20.03% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return

Parsons Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Parsons Capital Management held 361 positions worth $996M, up 7.9% from $923M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Parsons Capital Management's Q4 2019 filing shows 17 new, 88 increased, 159 reduced and 12 closed positions. Its largest new stake was Relmada Therapeutics: 366,933 shares worth $14.3M. The largest sale was Celgene Corp, an estimated $6.06M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • Parsons Capital Management's largest Q4 2019 buy was Relmada Therapeutics: 366,933 shares worth $14.3M.
  • Parsons Capital Management added most to Bristol-Myers Squibb in Q4 2019, an estimated $3.4M increase.
  • Parsons Capital Management's biggest Q4 2019 reduction was 3M, cutting an estimated $6.04M.
  • Parsons Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $6.06M.
  • Parsons Capital Management's ten largest holdings make up 32% of its $996M portfolio in Q4 2019.
  • Parsons Capital Management opened 17 new positions and closed 12 in Q4 2019.
  • Parsons Capital Management's portfolio value rose 7.9% quarter-over-quarter to $996M.

Based on Parsons Capital Management's 13F filing for Q4 2019, filed 3 Feb 2020.